Clinical Trial Update: The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation [NA]

View source ↗

Summary

Completed a clinical trial evaluating the EC90 of remifentanil to blunt hemodynamic changes during head fixation in patients with brain neoplasms, arteriovenous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformation
• Brain Neoplasms
• Intracerebral Hemorrhage

Drugs mentioned

• Remifentanil (remifentanil)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Brain Tumor, AVM | NA | Status: COMPLETED